Once Viewed as a Promising COVID-19 Treatment, Convalescent Plasma Falls Out of Favor
- PMID: 35262639
- DOI: 10.1001/jama.2022.3214
Once Viewed as a Promising COVID-19 Treatment, Convalescent Plasma Falls Out of Favor
Similar articles
-
Convalescent plasma therapy: A passive therapy for an aggressive COVID-19.J Med Virol. 2020 Nov;92(11):2251-2253. doi: 10.1002/jmv.26047. Epub 2020 Jun 9. J Med Virol. 2020. PMID: 32437024 Free PMC article. No abstract available.
-
Convalescent Plasma: A Potential Life-Saving Therapy for Coronavirus Disease 2019 (COVID-19).Front Public Health. 2020 Aug 6;8:437. doi: 10.3389/fpubh.2020.00437. eCollection 2020. Front Public Health. 2020. PMID: 32903641 Free PMC article. No abstract available.
-
Convalescent plasma to treat COVID-19: Following the Argentinian lead.Transfus Apher Sci. 2021 Jun;60(3):103161. doi: 10.1016/j.transci.2021.103161. Epub 2021 May 23. Transfus Apher Sci. 2021. PMID: 34045121 Free PMC article. Review. No abstract available.
-
Convalescent plasma for COVID-19 considerations.Transfus Apher Sci. 2021 Feb;60(1):102927. doi: 10.1016/j.transci.2020.102927. Epub 2020 Aug 27. Transfus Apher Sci. 2021. PMID: 32878733 Free PMC article. No abstract available.
-
Convalescent plasma - this is no time for competition.Transfusion. 2020 Jul;60(7):1644-1646. doi: 10.1111/trf.15922. Epub 2020 Jun 25. Transfusion. 2020. PMID: 32533558 Free PMC article. Review. No abstract available.
Cited by
-
Essential services: Quantifying the contributions of America's pharmacists in COVID-19 clinical interventions.J Am Pharm Assoc (2003). 2022 Nov-Dec;62(6):1929-1945.e1. doi: 10.1016/j.japh.2022.08.010. Epub 2022 Aug 18. J Am Pharm Assoc (2003). 2022. PMID: 36202712 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
